Purchase and supply of palivizumab
Original notice title
Poland – Infusion solutions – Zakup i sukcesywne dostawy leku palivizumab UCZKIN.ZP.07.2026.EU
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o.
- Country
- Poland
- CPV
- 33692100 - Infusion solutions
- Deadline
- Aug 04, 2026
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Dec 2026
- Supply of palivizumab (infusion solutions) for RS virus prophylaxis
- Delivery to Warsaw, Poland
Show full summary
This tender concerns the procurement of palivizumab (infusion solutions) for RS virus prophylaxis for the University Centre for Women's and Newborn Health in Warsaw, Poland. It is an open procedure for a single lot supply contract with award based solely on price. The contract period is from September to December 2026. The estimated value is not disclosed. The submission deadline is 4 August 2026 at 10:00 Warsaw time. EU funding is indicated in structured data but XML notice shows no EU funds. No procurement documents were analyzed.
Risks
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be able to supply the drug in required quantities
- Delivery to Warsaw, Poland
Administrative
- Electronic submission required via Open portal
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o.
Location
Warszawa, POL
Website
Identifier
NIP: 7010389279
Activity
Health
Lots (1)
LOT-0001
Purchase and successive deliveries of palivizumab
Supply of medicinal product for RS virus prophylaxis for the University Centre for Women's and Newborn Health in Warsaw.
Location
Duration
Category
Award Criteria
Deadline
Award details
C= (cena najtańszej oferty/ cena oferty badanej) x 100
Value note
Show original TED data
Original lot title
Zakup i sukcesywne dostawy leku palivizumab. UCZKIN.ZP.07.2026.EU
Original TED description
Dostawa produktu leczniczego stosowanego w profilaktyce zakażeń wirusem RS dla Uniwersyteckiego Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o. w Warszawie.
Procurement Details
- Publication date
- 29 Jun 2026
- Languages
- Polish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 447412-2026
Documents (2)
Similar tenders
Croatia – Infusion solutions – INFUZIJSKE OTOPINE
Poland – Pharmaceutical products – Dostawa produktów leczniczych - część nr 2
Poland – Pharmaceutical products – „Dostawa produktów leczniczych, środków specjalnego przeznaczenia żywieniowego, wyrobów medycznych, glukometrów, płynów kontrolnych oraz pasków do glukometrów do Apteki SP ZOZ Szpitala Wielospecjalistycznego w Jaworznie”
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
No procurement documents analyzed; eligibility criteria, required documents, and technical specifications are unknown.
Structured data indicates EU funding, but XML notice sets FundingProgramCode to 'no-eu-funds'. This could affect budget...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications